Cargando…

Cost-Effectiveness of Lung Cancer Screening Using Low-Dose Computed Tomography Based on Start Age and Interval in China: Modeling Study

BACKGROUND: Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer-related death in China. The effectiveness of screening for lung cancer has been reported to reduce lung cancer–specific and overall mortality, although the cost-effectiveness, optimal start age, and screeni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zixuan, Du, Lingbin, Li, Yuanyuan, Wang, Le, Wang, Youqing, Yang, Yi, Dong, Hengjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301557/ https://www.ncbi.nlm.nih.gov/pubmed/35793127 http://dx.doi.org/10.2196/36425

Ejemplares similares

Correction: Cost-Effectiveness of Lung Cancer Screening Using Low-Dose Computed Tomography Based on Start Age and Interval in China: Modeling Study
por: Zhao, Zixuan, et al.
Publicado: (2022)

Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China
por: Zhao, Zixuan, et al.
Publicado: (2022)

Preferred Lung Cancer Screening Modalities in China: A Discrete Choice Experiment
por: Zhao, Zixuan, et al.
Publicado: (2021)

Modeling the Cost-effectiveness of Esophageal Cancer Screening in China
por: Li, Yuanyuan, et al.
Publicado: (2020)

Uptake of lung cancer screening with low-dose computed tomography in China: A multi-centre population-based study
por: Cao, Wei, et al.
Publicado: (2022)

One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China
por: Wang, Le, et al.
Publicado: (2022)

Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study
por: Wang, Le, et al.
Publicado: (2023)

Lung cancer screening with low-dose computed tomography: National expenditures and cost-effectiveness
por: Zeng, Xiaohui, et al.
Publicado: (2022)

Early detection of lung cancer: Low-dose computed tomography screening in China
por: Zhao, Shi-Jun, et al.
Publicado: (2015)

China national lung cancer screening guideline with low-dose computed tomography (2015 version)
por: Zhou, Qing-hua, et al.
Publicado: (2015)

Cost-Effectiveness Analysis of Risk Factor-Based Lung Cancer Screening Program by Low-Dose Computer Tomography in Current Smokers in China
por: Zhang, Tiantian, et al.
Publicado: (2023)

Low-dose computed tomography for lung cancer screening in Anhui, China: A randomized controlled trial
por: Rong, Feng, et al.
Publicado: (2022)

Initial low-dose computed tomography screening results and summary of participant characteristics: based on the latest Chinese guideline
por: Zhang, Zixuan, et al.
Publicado: (2023)

Incidence and mortality of thyroid cancer in China, 2008−2012
por: Du, Lingbin, et al.
Publicado: (2019)

Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China
por: Guo, Lan-Wei, et al.
Publicado: (2020)

A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker
por: Toumazis, Iakovos, et al.
Publicado: (2021)

Expected Cost Savings From Low-Dose Computed Tomography Scan Screening for Lung Cancer in Alberta, Canada
por: Thanh, Nguyen Xuan, et al.
Publicado: (2022)

Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China
por: Du, Lingbin, et al.
Publicado: (2018)

Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019
por: Wang, Le, et al.
Publicado: (2022)

Dynamics of the QTc interval over a 24‐h dose interval after start of intravenous ciprofloxacin or low‐dose erythromycin administration in ICU patients
por: Berger, Florine A., et al.
Publicado: (2021)

Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice
por: Wang, Zixing, et al.
Publicado: (2017)

Cost-effectiveness of computed tomography lung cancer screening
por: Reich, Jerome M
Publicado: (2009)

Organ Dose and Attributable Cancer Risk in Lung Cancer Screening with Low-Dose Computed Tomography
por: Saltybaeva, Natalia, et al.
Publicado: (2016)

Accuracy of baseline low-dose computed tomography lung cancer screening: a systematic review and meta-analysis
por: Guo, Lanwei, et al.
Publicado: (2023)

Use of Lung Cancer Screening With Low-Dose Computed Tomography in the Medicare Population
por: Nishi, Shawn, et al.
Publicado: (2019)

Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe
por: Veronesi, Giulia, et al.
Publicado: (2020)

Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China
por: Zhen, Xuemei, et al.
Publicado: (2018)

Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis
por: Sun, Xueshan, et al.
Publicado: (2021)

Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals
por: Landy, Rebecca, et al.
Publicado: (2023)

Author response to “lack of benefit from low dose computed tomography in screening for lung cancer”
por: Huang, Kai-Lin, et al.
Publicado: (2020)

Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations
por: Gou, Hong-Feng, et al.
Publicado: (2016)

Automatic opportunistic osteoporosis screening using low-dose chest computed tomography scans obtained for lung cancer screening
por: Pan, Yaling, et al.
Publicado: (2020)

Comparison between thoracic low-dose computed tomography and conventional-dose computed tomography in evaluating anemia: A preliminary study in a Chinese screening cohort
por: Zhang, Jianing, et al.
Publicado: (2022)

Cost-effectiveness analysis of lung cancer screening with low-dose computerised tomography of the chest in Poland
por: Kanarkiewicz, Małgorzata, et al.
Publicado: (2015)

Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography
por: Toyoda, Y, et al.
Publicado: (2008)

Screening for lung cancer with Low-Dose Computed Tomography: a systematic review of the evidence
por: Iliopoulou, Sotiria-Maria E, et al.
Publicado: (2014)

What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?
por: Bradley, Stephen H, et al.
Publicado: (2021)

Low‐dose computed tomography lung cancer screening: Clinical evidence and implementation research
por: Lancaster, Harriet L., et al.
Publicado: (2022)

Performance of (18)F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism
por: Robin, Philippe, et al.
Publicado: (2017)

Impact of Low-Dose Computed Tomography on Computed Tomography Orders and Scan Length
por: Simmons, Curtis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rupto5edd7ot38jvs03hmrscua